War in Ukraine: Global cancer aid to support refugees

ASCO and WHO to collaborate on quality indicators for cancer facilities

Spotlight on global cancer control at ASCO 2022

UICC announces global coalition to increase access to essential cancer medicines in low and lower middle-income countries

METNET: A phase II trial of metformin in patients with well differentiated neuroendocrine tumours

Priorities of cancer research in Nepal

Implementing national cancer control plans

Role of radiologist in diagnosis and treatment of NET (neuroendocrine tumour)

Tumour shrinkage with ipilimumab plus nivolumab in patients with neuroendocrine carcinoma

Umbralisib shows early promise for patients with marginal zone lymphoma

Cytotoxic T lymphocyte cell therapy for post-transplant lymphoproliferative disorder in the central nervous system

Editor's Choice for June 2018